AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
MONDAY, April 8, 2024 -- An exosome-based liquid biopsy assay can distinguish patients with pancreatic ductal adenocarcinoma (PDAC) from healthy donors (HDs), according to a study presented at the annual meeting of the American Association for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients
Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a lower risk of disease recurrence and longer... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Less Than 50% of Accelerated Approvals Show Clinical Benefit Less Than 50% of Accelerated Approvals Show Clinical Benefit
A new study looks at 5-year outcomes of cancer drugs that were given accelerated approvals.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 8, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Have scientists cracked cancer mystery in young people? Experts think they've pinpointed bodily changes that are driving skyrocketing cancer rates in under 50s
Researchers from Washington University in St Louis found that people born after 1965 were more likely to have a biological age greater than their chronological age. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Can Late-Stage Cancer Incidence Serve as an Endpoint for Screening Trials?
(MedPage Today) -- SAN DIEGO -- While using an endpoint of late-stage cancer incidence may be a suitable alternative to cancer-specific mortality for some cancers in screening trials, it doesn't work for others, researchers said here.
A systematic... (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - April 8, 2024 Category: OBGYN Source Type: news
I put my night sweats down to early menopause - it was actually late stage blood cancer
Susete Isabel, 40, of Toronto, Canada, was diagnosed with stage four follicular lymphoma after mistaking her symptoms for early menopause, drinking, and working too much. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials
(MedPage Today) -- SAN DIEGO -- Most cancer drugs granted accelerated approval by the FDA have not demonstrated a benefit in overall survival (OS) or quality of life within 5 years, according to a cohort study presented here.
Of 46 cancer drug... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 8, 2024 Category: Hematology Source Type: news
Woman, 24, dies of cancer just months after complaining of a sore on her tongue
Her heartbroken parents are now campaigning for assisted dying to spare the suffering of others (Source: Daily Express - Health)
Source: Daily Express - Health - April 8, 2024 Category: Consumer Health News Source Type: news
AACR: Little Benefit Seen for Cancer Drugs Given Accelerated Approval
MONDAY, April 8, 2024 -- Most cancer drugs granted accelerated approval do not demonstrate clinical benefit, according to a study published online April 7 in the Journal of the American Medical Association to coincide with the annual meeting of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Blood Test Spots Early Pancreatic Cancers With 97% Accuracy
MONDAY, April 8, 2024 -- A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports.The test looks for eight small RNA particles and eight larger DNA markers shed by pancreatic cancers,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 8, 2024 Category: General Medicine Source Type: news
Single Invitation for PSA Screening Cuts Prostate Cancer Deaths
MONDAY, April 8, 2024 -- A single invitation for prostate-specific antigen (PSA) screening is associated with reduced prostate cancer deaths, although the absolute reduction is small, according to a study published online April 6 in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Immersive Virtual Reality Beneficial for Pain Relief in Cancer
MONDAY, April 8, 2024 -- For hospitalized patients with cancer, immersive virtual reality (VR) distraction therapy is associated with a greater reduction in pain compared with an active control, according to a study published online April 8 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Breakthrough in fight against world's deadliest cancer - new drug shrunk up to 70% of pancreatic tumors in lab study
An experimental drug for aggressive, deadly pancreatic cancer effectively shrunk nearly all tumors tested, a new lab study found. (Source: the Mail online | Health)
Source: the Mail online | Health - April 8, 2024 Category: Consumer Health News Source Type: news
Allterum Therapeutics receives $12 million product development grant from CPRIT to advance anti-CD127 therapeutic antibody into clinic
Allterum Therapeutics, Inc. has been awarded a $12 million product development grant from the Cancer Prevention and Research Institute of Texas (CPRIT). This grant will support the clinical evaluation of Allterum's 4A10 monoclonal antibody targeting CD127, a receptor that is expressed in... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2024 Category: Pharmaceuticals Tags: AWD Source Type: news
Efforts to support Palestinian scientists struggle with the realities of war
Mou’yed Issa Talab Ismail was thrilled when, last month, he received an offer to begin a doctoral program in medical physics at the University of Sherbrooke. “Canada is considered one of the best countries in the world in my field of scientific research,” he says. “This will open the way for me to complete my studies.”
One of several recently launched efforts to support scientists and technical students in war-torn Gaza helped match Ismail with the Canadian program. But throwing a lifeline to Palestinian scholars is proving difficult, and it’s unclear when Ismail will make it to Canada. He is currently sh...
Source: ScienceNOW - April 8, 2024 Category: Science Source Type: news
